JOHNSON & JOHNSON (JNJ) vs STARBUCKS CORP(SBUX)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | JNJ | SBUX |
|---|---|---|
| Sector | Health Care | Consumer Discretionary |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $94.19B | $37.18B |
| Revenue growth (YoY) | ▲ 6.0% | ▲ 2.8% |
| Net income | $26.80B | $1.86B |
| Gross margin | 67.9% | — |
| Diluted EPS | $11.03 | $1.63 |
| Insider net (6 mo) | −40.8K sh · 6 sells · 0 buys | +15.6K sh · 11 sells · 0 buys |
| Institutional owners | 47 | 47 |
| Institutional value held | $294.77B | $77.82B |
| Next earnings (est.) | Around Oct 13, 2026 | Oct 28, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About JOHNSON & JOHNSON (JNJ)
Johnson & Johnson, incorporated in New Jersey in 1887, is a global healthcare holding company with approximately 138,200 full-time-equivalent employees engaged in the research, development, manufacture, and sale of a broad range of healthcare products.
About STARBUCKS CORP (SBUX)
Starbucks Corporation, formed in 1985 and traded on Nasdaq under the symbol "SBUX," is the premier roaster, marketer, and retailer of specialty coffee in the world, operating in 89 markets as of the fiscal year ended September 28, 2025.
Source: SEC EDGAR.